This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
January 09, 2017
Strongbridge Biopharma plc Expands Commercial Capabilities with Two Rare Disease Executive Hires
January 05, 2017
Targovax announces appointment of Erik Digman Wiklund as CFO
January 05, 2017
Nexstim to present at Biotech Showcase 9th Annual Conference in San Francisco
January 05, 2017
Aprea Therapeutics Announces Presentation at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco
January 04, 2017
Strongbridge Biopharma plc to Present at Biotech Showcase 2017
January 04, 2017
Nordic Nanovector to Present at Biotech Showcase 2017
December 23, 2016
Strongbridge Biopharma plc Provides Corporate and Financial Update
December 23, 2016
Strongbridge Biopharma plc Announces Acquisition of U.S. Rights to KEVEYIS® From Taro
December 23, 2016
Strongbridge Biopharma plc Announces $35 Million Equity Financing
December 21, 2016
Nexstim Plc receives FDA’s response to the proposed limited size stroke trial plan